CPB CAMPBELL'S Co
Food and Kindred Products · Nasdaq · SEC CIK 16732 · Fiscal year ends 08/03
Financial factors as of 2026-08-02 (2026Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY-5.0%
TTM net income YoY-33.1%
TTM EPS YoY-34.8%
Revenue 3-yr CAGR1.4%
Net income 3-yr CAGR-22.3%
Margins
Gross margin28.1%
Operating margin8.7%
Net margin4.1%
FCF margin7.0%
EBITDA margin13.0%
Returns
ROE10.4%
ROA2.6%
ROIC (approx.)6.1%
Asset turnover0.64x
Leverage & solvency
Liabilities / assets73.4%
Debt / equity1.85x
Current ratio0.82x
Interest coverage2.57x
Cash quality & payout
Operating cash flow / net income2.58x
Accruals ratio-4.2%
Payout ratio116.6%
Capex / revenue3.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-08-02 | FY20252025-08-03 |
|---|---|---|
| Income statement | ||
| Revenue | $9.74B | $10.25B |
| Cost of revenue | $7.00B | $7.13B |
| Gross profit | $2.74B | $3.12B |
| R&D expense | $99.00M | $100.00M |
| SG&A expense | $646.00M | $674.00M |
| Operating income | $852.00M | $1.12B |
| Interest expense | $331.00M | $345.00M |
| Pretax income | $529.00M | $796.00M |
| Income tax | $124.00M | $194.00M |
| Net income | $403.00M | $602.00M |
| EBITDA | $1.26B | $1.56B |
| EPS (basic) | 1.34 | 2.02 |
| EPS (diluted) | 1.31 | 2.01 |
| Dividends declared per share | 1.56 | 1.54 |
| Weighted avg. shares (diluted) | 300.00M | 300.00M |
| Balance sheet | ||
| Cash & equivalents | $394.00M | $132.00M |
| Receivables | $517.00M | $541.00M |
| Inventory | $1.61B | $1.42B |
| Current assets | $2.72B | $2.23B |
| PP&E, net | $2.87B | $2.77B |
| Goodwill | $5.32B | $4.99B |
| Intangibles | $4.20B | $4.36B |
| Total assets | $15.65B | $14.90B |
| Current liabilities | $3.34B | $2.91B |
| Short-term debt | $977.00M | $762.00M |
| Long-term debt | $6.16B | $6.09B |
| Total debt | $7.14B | $6.86B |
| Total liabilities | $11.49B | $10.99B |
| Shareholders' equity | $3.85B | $3.90B |
| Net debt | $6.74B | $6.72B |
| Cash flow statement | ||
| Operating cash flow | $1.04B | $1.13B |
| Capital expenditure | $361.00M | $426.00M |
| Free cash flow | $678.00M | $705.00M |
| Investing cash flow | -$357.00M | -$187.00M |
| Financing cash flow | -$419.00M | -$919.00M |
| Depreciation & amortization | $413.00M | $434.00M |
| Stock-based compensation | $56.00M | $57.00M |
| Dividends paid | $470.00M | $459.00M |
| Share buybacks | $26.00M | $62.00M |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.